Delivery Order SPE2DB22D9353-SPE2DB25FX2GC
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in 30-count packaging. This delivery order was awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, utilizing firm fixed-price pricing with no set-aside designation. The order represents a discrete fulfillment under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. for 34 mg Nuplazid capsules (30-count units) on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a single line item fulfillment under DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units) with an ultimate completion date of September 26, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its primary location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. on August 26, 2025, for the supply of Nuplazid 34 mg capsules in quantities of 30. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a continuation of the ongoing pharmaceutical supply relationship between DLA and the Park Ridge, Illinois-based vendor. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The award, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, carries no set-aside designation. This delivery order represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $10,375.53 delivery order to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Nuplazid 34 mg capsules in quantities of 30 units. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, carries no set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to fulfill this requirement through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,458.51 on July 14, 2025, for the supply of Nuplazid 34 mg capsules (30-count packages) under contract 4568809623. The award utilizes firm fixed-price pricing with no set-aside designation and is scheduled for completion by August 4, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 20, 2025. The contract covers the supply of Nuplazid 34 mg capsules in quantities of 30, with a firm fixed-price structure and an ultimate completion date of September 11, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an...
- On July 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units). This firm fixed-price delivery order is expected to be completed by July 23, 2025, and represents a specific fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program. The vendor, a woman-owned small business pharmaceutical wholesaler based in Park...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,375.53 by the Defense Logistics Agency for Nuplazid 34 mg capsules (30-count units). The contract, issued on June 3, 2025, with an ultimate completion date of June 25, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2GCDelivery Order
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on September 29, 2025, for the supply of Nuplazid (pimavanserin) 34 mg capsules in quantities of 30 units. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this delivery order under a firm fixed-price contract with a ceiling value of $10,375.53. The order represents no set-aside designation and carries an ultimate completion date of October 21, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the agency to procure an extensive range of pharmaceutical products supporting military healthcare facilities. DMS Pharmaceutical Group has established itself as a key supplier in the federal pharmaceutical supply chain through its primary contracting relationship with the Defense Logistics Agency. The company specializes in providing branded and generic prescription medications, biologics, and medical consumables to Department of Defense healthcare systems nationwide. This particular delivery order for Nuplazid, an antipsychotic medication used in the treatment of Parkinson's disease psychosis, reflects the vendor's role in supplying specialized pharmaceutical products to support military medical requirements. The firm fixed-price structure and short completion timeline underscore the operational efficiency of the Indefinite Delivery Contract vehicle in meeting urgent pharmaceutical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 9/29/25 |